The Cannabis Alliance

Legislation to alter a planned transfer of cannabis lab accreditation authority was broadly praised by the sponsor, agency leaders, and cannabis sector stakeholders. 

By the end of Tuesday, Representatives tasked with oversight of the adult-use cannabis market were scheduled to have heard five bills and considered moving two in the first days of the week.

A bill to make cannabis business bans the purview of voters rather than their elected officials drew pushback from local government interests and support from an industry stakeholder.

Cannabis waste legislation was advanced, another hemp bill may be on the way, the first cannabis-related bills were heard, and two new bills were scheduled for introduction.

Organization leaders and attendees heard from two prominent legislators on long-running cannabis topics and expected priorities for the 2024 regular legislative session.

DOH staff heard stories and suggestions from patients, advocates, and other stakeholders on how to improve affordability, access, and understanding of medically compliant cannabis products.

Updates to a more than five-year-old tribal compact, a rulemaking petition, and general public comments were on the agenda for the final board meeting of 2023.

As legislators sought perspectives on contemporary cannabis policy issues and regulators willingly shared, a group of publicly-funded prevention researchers kept their doors closed.

Licensees gave another round of feedback to agency staff engaged in rulemaking on how to set limits and requirements for cannabis product sampling by retail staff.

A mostly new team at the DOH Medical Cannabis Program solicited feedback on potential revisions to rules on compliant products, testing, labeling, and logos.